RCT Abstract - Acetazolamide to prevent impending altitude-related adverse health effects in COPD patients. RCT

Conclusion: In lowlanders with COPD, travelling to 3100m, SSM-guided preventive acetazolamide therapy reduced the incidence of ARAHE. This novel approach may allow to restrict the use of preventive acetazolamide therapy to patients at risk.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Furian, M., Reiser, A., Mademilov, M., Bitos, K., Buenzli, S., Abdraeva, A., Champigneulle, B., Carta, A., Bauer, M., Ulrich, T., Mueller, J., Grimm, M., Schneider, S., Shakiev, N., Taalaibekova, A., Ozonova, A., Magdieva, K., Mirzalieva, G., Akylbekov, A Tags: Clinical and epidemiological respiratory sleep medicine Source Type: research